Arcadia Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-87
Closed -$9K 299
2019
Q3
$9K Sell
87
-200
-70% -$19K ﹤0.01% 276
2019
Q2
$27K Sell
287
-325
-53% -$30.9K 0.01% 248
2019
Q1
$58K Hold
612
0.02% 186
2018
Q4
$39K Sell
612
-825
-57% -$60.9K 0.01% 204
2018
Q3
$129K Buy
1,437
+299
+26% +$26.4K 0.03% 138
2018
Q2
$90K Hold
1,138
0.03% 167
2018
Q1
$102K Hold
1,138
0.03% 160
2017
Q4
$119K Buy
1,138
+401
+54% +$45.2K 0.03% 150
2017
Q3
$107K Buy
737
+400
+119% +$54.5K 0.03% 155
2017
Q2
$44K Hold
337
0.01% 230
2017
Q1
$42K Buy
337
+87
+35% +$10.4K 0.01% 232
2016
Q4
$29K Sell
250
-80
-24% -$8.91K 0.01% 243
2016
Q3
$34K Sell
330
-633
-66% -$68.5K 0.01% 228
2016
Q2
$95K Buy
+963
New +$99.6K 0.03% 149

Other funds holding CELG

Arcadia Investment Management's CELG Position: Q4 2019 in Review

Arcadia Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 87 shares — an estimated $9K sold.

Arcadia Investment Management first reported a position in CELG in Q2 2016 and held it in 14 quarters. The position peaked at $129K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Arcadia Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Arcadia Investment Management sold 87 Celgene Corp shares in Q4 2019, an estimated $9K.
  • Arcadia Investment Management first reported a position in Celgene Corp in Q2 2016 and held it in 14 quarters.
  • Arcadia Investment Management's Celgene Corp position peaked at $129K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Arcadia Investment Management's 13F filing for Q4 2019, filed 29 Jan 2020.